• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化部分凝血活酶时间可预测发热伴血小板减少综合征患者的死亡率:中国北方一项多中心研究

Activated partial thromboplastin time predicts mortality in patients with severe fever with thrombocytopenia syndrome: A multicenter study in north China.

作者信息

Peng Wenjuan, Li Junnan, Yu Hong, Zhou Wei, Lin Ling, Ge Ziruo, Lai Jianming, Chen Zhihai, Zhu Liuluan, Zhao Zhenghua, Shen Yi, Jin Ronghua, Duan Jianping, Zhang Wei

机构信息

Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Beijing Institute of Infectious Diseases, Beijing, China.

出版信息

Heliyon. 2024 May 22;10(11):e31289. doi: 10.1016/j.heliyon.2024.e31289. eCollection 2024 Jun 15.

DOI:10.1016/j.heliyon.2024.e31289
PMID:38867977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11167268/
Abstract

BACKGROUND

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high lethality. This study aimed to determine whether prolonged activated partial thromboplastin time (APTT) predicted SFTS mortality.

METHODS

SFTS patients were enrolled from 6 hospitals in the north China. Subjects were divided into training cohort and 5 externally validation cohorts. The least absolute shrinkage and selection operator Cox regression model was performed to screen potential prognostic factors. Risk factors were analyzed using multivariable regression models. Prognostic models were established by Cox regression and random survival forest (RSF) methods, and evaluated regarding discrimination, validity and clinical benefit. Time-dependent receiver operating characteristic (ROC) curve was used to evaluate the predictive effectiveness of variables.

RESULTS

1332 SFTS cases were included, in which 211 patients died. Six potential prognostic factors were screened, and pulse, breath, APTT and aspartic transaminase (AST) were independently associated with mortality in both training cohort (Yantai, N = 791) and external validation cohort (N = 541). APTT was steadily correlated with the fatality (HR: 1.039-1.144; all  < 0.01) in each five sub-validation cohorts (Dandong, Dalian, Tai'an, Qingdao and Beijing). RSF model with variables of APTT, AST, pulse and breath had considerable prognostic effectiveness, which APTT showed the highest prognostic ability with the area under the curve of 0.848 and 0.787 for 7-day and 14-day survival, respectively. Survival differences were found between high and low levels of APTT for mortality using 50s as the optimal cut-off.

CONCLUSIONS

SFTS patients have prolonged APTT, which is an independent risk factor for fatality. APTT≥50s was recommended as a biomarker to remind physicians to monitor and treat patients more aggressively to improve clinical prognosis.

摘要

背景

发热伴血小板减少综合征(SFTS)是一种新出现的致死率较高的传染病。本研究旨在确定活化部分凝血活酶时间(APTT)延长是否可预测SFTS患者的死亡率。

方法

从中国北方6家医院招募SFTS患者。将受试者分为训练队列和5个外部验证队列。采用最小绝对收缩和选择算子Cox回归模型筛选潜在的预后因素。使用多变量回归模型分析危险因素。通过Cox回归和随机生存森林(RSF)方法建立预后模型,并对其判别能力、有效性和临床效益进行评估。采用时间依赖性受试者工作特征(ROC)曲线评估变量的预测有效性。

结果

共纳入1332例SFTS病例,其中211例死亡。筛选出6个潜在的预后因素,脉搏、呼吸、APTT和天门冬氨酸转氨酶(AST)在训练队列(烟台,N = 791)和外部验证队列(N = 541)中均与死亡率独立相关。在每一个五个子验证队列(丹东、大连、泰安、青岛和北京)中,APTT均与死亡率呈稳定相关(HR:1.039 - 1.144;均P < 0.01)。包含APTT、AST、脉搏和呼吸变量的RSF模型具有相当的预后效果,其中APTT的预后能力最强,7天和14天生存曲线下面积分别为0.848和0.787。以50秒作为最佳截断值,发现APTT高低水平之间在死亡率方面存在生存差异。

结论

SFTS患者APTT延长,这是死亡的独立危险因素。建议将APTT≥50秒作为生物标志物,提醒医生更积极地监测和治疗患者,以改善临床预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/ff61000dd29b/mmcfigs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/c66e5e2b5a12/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/edf8e0ac96ff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/0d401ffff10f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/b8b2512ca9fd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/a4b9721dacd0/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/ff61000dd29b/mmcfigs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/c66e5e2b5a12/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/edf8e0ac96ff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/0d401ffff10f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/b8b2512ca9fd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/a4b9721dacd0/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aee/11167268/ff61000dd29b/mmcfigs2.jpg

相似文献

1
Activated partial thromboplastin time predicts mortality in patients with severe fever with thrombocytopenia syndrome: A multicenter study in north China.活化部分凝血活酶时间可预测发热伴血小板减少综合征患者的死亡率:中国北方一项多中心研究
Heliyon. 2024 May 22;10(11):e31289. doi: 10.1016/j.heliyon.2024.e31289. eCollection 2024 Jun 15.
2
The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.AST/ALT 比值(De Ritis 比值)反映了早期发热伴血小板减少综合征患者的不良预后:一项观察性队列研究。
Front Cell Infect Microbiol. 2022 Feb 8;12:725642. doi: 10.3389/fcimb.2022.725642. eCollection 2022.
3
MCP-3 as a prognostic biomarker for severe fever with thrombocytopenia syndrome: a longitudinal cytokine profile study.MCP-3 作为发热伴血小板减少综合征严重程度的预后生物标志物:一项纵向细胞因子谱研究。
Front Immunol. 2024 May 15;15:1379114. doi: 10.3389/fimmu.2024.1379114. eCollection 2024.
4
High C-reactive protein to lymphocyte ratio predicts mortality outcomes of patients with severe fever with thrombocytopenia syndrome: A multicenter study in China.高C反应蛋白与淋巴细胞比值可预测发热伴血小板减少综合征患者的死亡结局:一项中国多中心研究
J Med Virol. 2023 Feb;95(2):e28546. doi: 10.1002/jmv.28546.
5
Increased cTnI Predicts Early Death in Patients with Severe Fever with Thrombocytopenia: A Multicenter Study in North China.肌钙蛋白I升高预示严重发热伴血小板减少症患者的早期死亡:一项中国北方的多中心研究。
Infect Drug Resist. 2024 Jun 21;17:2579-2590. doi: 10.2147/IDR.S463251. eCollection 2024.
6
Risk factors for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: A multicenter retrospective study.严重发热伴血小板减少综合征患者侵袭性肺曲霉病的危险因素:一项多中心回顾性研究。
J Med Virol. 2024 May;96(5):e29647. doi: 10.1002/jmv.29647.
7
Prediction of Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome.严重发热伴血小板减少综合征患者的预后预测
Jpn J Infect Dis. 2025 Jan 23;78(1):28-34. doi: 10.7883/yoken.JJID.2024.015. Epub 2024 Sep 30.
8
The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Patients With Severe Fever With Thrombocytopenia Syndrome.严重发热伴血小板减少综合征患者C反应蛋白与白蛋白比值的预后意义
Front Med (Lausanne). 2022 Apr 29;9:879982. doi: 10.3389/fmed.2022.879982. eCollection 2022.
9
NLR, A Convenient Early-Warning Biomarker of Fatal Outcome in Patients With Severe Fever With Thrombocytopenia Syndrome.中性粒细胞与淋巴细胞比值,一种方便的严重发热伴血小板减少综合征患者致命结局的早期预警生物标志物。
Front Microbiol. 2022 Jun 23;13:907888. doi: 10.3389/fmicb.2022.907888. eCollection 2022.
10
Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis.严重发热伴血小板减少综合征患者的临床实验室参数与病死率:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2022 Jun 17;16(6):e0010489. doi: 10.1371/journal.pntd.0010489. eCollection 2022 Jun.

引用本文的文献

1
Prediction of Mortality by Clinical Laboratory Parameters in Severe Fever with Thrombocytopenia Syndrome: A Meta-Analysis.通过临床实验室参数预测发热伴血小板减少综合征患者的死亡率:一项Meta分析
Trop Med Infect Dis. 2025 Jul 9;10(7):193. doi: 10.3390/tropicalmed10070193.
2
Dynamic changes of activated partial thromboplastin time and correlation with mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study.发热伴血小板减少综合征患者活化部分凝血活酶时间的动态变化及其与死亡率的相关性:一项回顾性队列研究
PLoS Negl Trop Dis. 2025 May 22;19(5):e0013106. doi: 10.1371/journal.pntd.0013106. eCollection 2025 May.
3

本文引用的文献

1
A novel necroptosis related gene signature and regulatory network for overall survival prediction in lung adenocarcinoma.一种新的与坏死性凋亡相关的基因特征和调控网络,用于预测肺腺癌的总体生存率。
Sci Rep. 2023 Sep 15;13(1):15345. doi: 10.1038/s41598-023-41998-2.
2
Liver Function Derangement in Patients with Severe Fever and Thrombocytopenia Syndrome.严重发热伴血小板减少综合征患者的肝功能紊乱
J Clin Transl Hepatol. 2022 Oct 28;10(5):825-834. doi: 10.14218/JCTH.2021.00345. Epub 2022 Jan 14.
3
Analysis of risk factors associated with fatal outcome among severe fever with thrombocytopenia syndrome patients from 2015 to 2019 in Shandong, China.
A machine learning model for mortality prediction in patients with severe fever with thrombocytopenia syndrome: a prospective, multicenter cohort study.
用于严重发热伴血小板减少综合征患者死亡率预测的机器学习模型:一项前瞻性、多中心队列研究。
Emerg Microbes Infect. 2025 Dec;14(1):2498572. doi: 10.1080/22221751.2025.2498572. Epub 2025 Jun 19.
2015 年至 2019 年中国山东严重发热伴血小板减少综合征患者死亡结局相关危险因素分析。
Eur J Clin Microbiol Infect Dis. 2022 Dec;41(12):1415-1420. doi: 10.1007/s10096-022-04506-4. Epub 2022 Oct 11.
4
Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis.严重发热伴血小板减少综合征患者的临床实验室参数与病死率:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2022 Jun 17;16(6):e0010489. doi: 10.1371/journal.pntd.0010489. eCollection 2022 Jun.
5
Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome.用人源化小鼠感染一种新型沙粒病毒可呈现出严重发热伴血小板减少综合征的致病特征。
PLoS Pathog. 2021 May 11;17(5):e1009587. doi: 10.1371/journal.ppat.1009587. eCollection 2021 May.
6
Correlation between thrombocytopenia and host response in severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征中血小板减少与宿主反应的相关性。
PLoS Negl Trop Dis. 2020 Oct 29;14(10):e0008801. doi: 10.1371/journal.pntd.0008801. eCollection 2020 Oct.
7
Why does activated partial thromboplastin time prolongation occur in severe fever with thrombocytopenia syndrome?为什么在重型发热伴血小板减少综合征中会出现活化部分凝血活酶时间延长?
BMJ Case Rep. 2020 Oct 8;13(10):e235447. doi: 10.1136/bcr-2020-235447.
8
Analysis of Severe Fever With Thrombocytopenia Syndrome in Critical Ill Patients in Central China.华中地区危重症严重发热伴血小板减少综合征患者分析。
Shock. 2020 Oct;54(4):451-457. doi: 10.1097/SHK.0000000000001527.
9
Analysis of the laboratory indexes and risk factors in 189 cases of severe fever with thrombocytopenia syndrome.189例发热伴血小板减少综合征患者实验室指标及危险因素分析
Medicine (Baltimore). 2020 Jan;99(2):e18727. doi: 10.1097/MD.0000000000018727.
10
Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections.严重发热伴血小板减少综合征病毒在致死性人类感染中靶向B细胞。
J Clin Invest. 2020 Feb 3;130(2):799-812. doi: 10.1172/JCI129171.